EGFR and non-small cell lung carcinoma: Additionally, another study has demonstrated that it inhibited cell proliferation and induced apoptosis by targeting epidermal growth factor receptor (EGFR) and mesenchymal-to-epithelial transition (MET) factor in gefitinib-sensitive and gefitinib-resistant non-small-cell lung cancer (NSCLC) cells [53].